Kristin Mekeel
Concepts (353)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 26 | 2026 | 711 | 2.990 |
Why?
| | Liver Transplantation | 22 | 2025 | 831 | 2.210 |
Why?
| | Organ Transplantation | 7 | 2024 | 251 | 1.290 |
Why?
| | Liver Diseases | 8 | 2015 | 304 | 1.250 |
Why?
| | Pancreas Transplantation | 7 | 2011 | 71 | 1.200 |
Why?
| | Tissue Donors | 10 | 2026 | 421 | 1.180 |
Why?
| | Graft Survival | 12 | 2026 | 519 | 1.140 |
Why?
| | Laparoscopy | 11 | 2016 | 481 | 1.090 |
Why?
| | Nephrectomy | 6 | 2020 | 161 | 1.070 |
Why?
| | Hepatectomy | 8 | 2015 | 274 | 0.980 |
Why?
| | Kidney Failure, Chronic | 7 | 2021 | 600 | 0.960 |
Why?
| | Liver Cirrhosis | 4 | 2022 | 287 | 0.910 |
Why?
| | Liver Neoplasms | 7 | 2022 | 779 | 0.880 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2022 | 372 | 0.880 |
Why?
| | Postoperative Complications | 16 | 2024 | 2962 | 0.870 |
Why?
| | Living Donors | 7 | 2018 | 282 | 0.870 |
Why?
| | Kidney | 5 | 2021 | 1498 | 0.710 |
Why?
| | Hepatic Stellate Cells | 1 | 2020 | 14 | 0.640 |
Why?
| | Renal Nutcracker Syndrome | 1 | 2020 | 8 | 0.620 |
Why?
| | Tissue and Organ Procurement | 5 | 2026 | 341 | 0.600 |
Why?
| | Bile Ducts, Intrahepatic | 4 | 2013 | 63 | 0.590 |
Why?
| | Waiting Lists | 5 | 2020 | 266 | 0.580 |
Why?
| | Students, Medical | 1 | 2023 | 375 | 0.560 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 108 | 0.550 |
Why?
| | Hepatitis C | 5 | 2025 | 257 | 0.540 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 131 | 0.540 |
Why?
| | Cysts | 2 | 2008 | 112 | 0.520 |
Why?
| | Renal Artery | 2 | 2015 | 43 | 0.510 |
Why?
| | Graft Rejection | 7 | 2015 | 519 | 0.510 |
Why?
| | Diabetes Mellitus | 4 | 2021 | 1076 | 0.480 |
Why?
| | Blood Vessel Prosthesis Implantation | 3 | 2013 | 228 | 0.480 |
Why?
| | Hepatitis B | 1 | 2016 | 66 | 0.460 |
Why?
| | Tissue and Organ Harvesting | 1 | 2015 | 78 | 0.440 |
Why?
| | Humans | 80 | 2026 | 145491 | 0.430 |
Why?
| | Vascular Diseases | 2 | 2015 | 252 | 0.420 |
Why?
| | Transplant Recipients | 4 | 2025 | 180 | 0.420 |
Why?
| | Retrospective Studies | 27 | 2026 | 17269 | 0.410 |
Why?
| | Middle Aged | 37 | 2026 | 36176 | 0.410 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2023 | 265 | 0.410 |
Why?
| | Salvage Therapy | 1 | 2015 | 165 | 0.400 |
Why?
| | Adult | 36 | 2026 | 40707 | 0.390 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1150 | 0.390 |
Why?
| | Internship and Residency | 1 | 2023 | 1265 | 0.380 |
Why?
| | Operating Rooms | 2 | 2024 | 144 | 0.350 |
Why?
| | Vena Cava, Inferior | 2 | 2013 | 81 | 0.340 |
Why?
| | Sphincterotomy, Transduodenal | 1 | 2011 | 2 | 0.340 |
Why?
| | Hernia, Ventral | 2 | 2009 | 24 | 0.330 |
Why?
| | Pancreatectomy | 2 | 2011 | 288 | 0.330 |
Why?
| | Viremia | 2 | 2025 | 160 | 0.330 |
Why?
| | Biliary Tract Diseases | 2 | 2012 | 33 | 0.330 |
Why?
| | Treatment Outcome | 25 | 2026 | 11831 | 0.330 |
Why?
| | Ampulla of Vater | 1 | 2011 | 40 | 0.320 |
Why?
| | Hepacivirus | 2 | 2025 | 244 | 0.320 |
Why?
| | Female | 42 | 2026 | 78763 | 0.300 |
Why?
| | Follow-Up Studies | 14 | 2025 | 5426 | 0.300 |
Why?
| | Spleen | 1 | 2011 | 511 | 0.300 |
Why?
| | Rhabdomyolysis | 1 | 2009 | 24 | 0.290 |
Why?
| | Ascites | 1 | 2009 | 48 | 0.290 |
Why?
| | Male | 39 | 2026 | 72817 | 0.280 |
Why?
| | Pancreas | 1 | 2011 | 341 | 0.280 |
Why?
| | Peritonitis | 1 | 2009 | 83 | 0.280 |
Why?
| | Echinococcosis, Hepatic | 1 | 2007 | 2 | 0.270 |
Why?
| | Gallbladder Neoplasms | 1 | 2007 | 20 | 0.260 |
Why?
| | Cholecystectomy | 1 | 2007 | 61 | 0.250 |
Why?
| | Risk Assessment | 2 | 2016 | 3759 | 0.250 |
Why?
| | Bacterial Infections | 1 | 2009 | 247 | 0.250 |
Why?
| | Aged | 18 | 2025 | 26125 | 0.250 |
Why?
| | Brain Death | 1 | 2026 | 59 | 0.230 |
Why?
| | Stents | 2 | 2012 | 570 | 0.230 |
Why?
| | Intraoperative Complications | 1 | 2007 | 157 | 0.230 |
Why?
| | Reoperation | 3 | 2020 | 631 | 0.230 |
Why?
| | Morbidity | 2 | 2023 | 322 | 0.230 |
Why?
| | Mucormycosis | 1 | 2005 | 18 | 0.230 |
Why?
| | Quality Improvement | 2 | 2026 | 1294 | 0.220 |
Why?
| | Portal Vein | 4 | 2016 | 116 | 0.210 |
Why?
| | Liver Failure | 2 | 2017 | 83 | 0.210 |
Why?
| | Beluga Whale | 1 | 2024 | 1 | 0.210 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2005 | 167 | 0.200 |
Why?
| | Robotic Surgical Procedures | 1 | 2026 | 183 | 0.200 |
Why?
| | Incidence | 3 | 2016 | 2915 | 0.200 |
Why?
| | Organ Preservation | 1 | 2024 | 125 | 0.190 |
Why?
| | Coinfection | 1 | 2025 | 144 | 0.190 |
Why?
| | Materia Medica | 1 | 2023 | 1 | 0.190 |
Why?
| | Pancreatic Neoplasms | 1 | 2011 | 928 | 0.190 |
Why?
| | Perfusion | 1 | 2024 | 249 | 0.190 |
Why?
| | Surgical Procedures, Operative | 1 | 2026 | 272 | 0.190 |
Why?
| | Anemia, Sickle Cell | 1 | 2007 | 318 | 0.190 |
Why?
| | Body Weight | 1 | 2007 | 970 | 0.180 |
Why?
| | Morphine Derivatives | 1 | 2022 | 19 | 0.180 |
Why?
| | Tablets | 1 | 2022 | 41 | 0.180 |
Why?
| | Liver Failure, Acute | 1 | 2023 | 68 | 0.180 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2023 | 138 | 0.170 |
Why?
| | Antiviral Agents | 4 | 2025 | 772 | 0.170 |
Why?
| | Acute Kidney Injury | 1 | 2009 | 873 | 0.170 |
Why?
| | Delayed Graft Function | 3 | 2026 | 46 | 0.170 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 6070 | 0.170 |
Why?
| | Time Factors | 9 | 2023 | 7171 | 0.160 |
Why?
| | Glomerular Filtration Rate | 3 | 2015 | 765 | 0.160 |
Why?
| | Consent Forms | 1 | 2020 | 12 | 0.160 |
Why?
| | Length of Stay | 4 | 2015 | 1348 | 0.160 |
Why?
| | Drug Prescriptions | 1 | 2022 | 287 | 0.150 |
Why?
| | Endoscopy, Digestive System | 2 | 2012 | 141 | 0.150 |
Why?
| | Pancreaticoduodenectomy | 3 | 2016 | 137 | 0.150 |
Why?
| | Creatinine | 4 | 2015 | 513 | 0.150 |
Why?
| | Recombination, Genetic | 2 | 1997 | 205 | 0.140 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 298 | 0.140 |
Why?
| | Prognosis | 4 | 2025 | 4323 | 0.140 |
Why?
| | Patient Selection | 3 | 2014 | 742 | 0.140 |
Why?
| | Mycophenolic Acid | 2 | 2010 | 120 | 0.140 |
Why?
| | Vaccination | 2 | 2024 | 1423 | 0.140 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 355 | 0.130 |
Why?
| | Leadership | 1 | 2022 | 401 | 0.130 |
Why?
| | Survival Analysis | 4 | 2010 | 1374 | 0.130 |
Why?
| | Gallbladder Diseases | 2 | 2007 | 11 | 0.130 |
Why?
| | Tomography, X-Ray Computed | 7 | 2016 | 2772 | 0.130 |
Why?
| | Granuloma, Plasma Cell | 1 | 2016 | 12 | 0.130 |
Why?
| | Risk Factors | 8 | 2025 | 10874 | 0.130 |
Why?
| | Renal Dialysis | 1 | 2021 | 465 | 0.130 |
Why?
| | Hypertension, Portal | 2 | 2007 | 66 | 0.120 |
Why?
| | Cystic Fibrosis | 1 | 2007 | 1173 | 0.120 |
Why?
| | Recurrence | 5 | 2018 | 1142 | 0.120 |
Why?
| | Antibodies, Monoclonal | 5 | 2010 | 1511 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 1999 | 536 | 0.120 |
Why?
| | Duodenal Neoplasms | 1 | 2016 | 26 | 0.120 |
Why?
| | Iliac Artery | 2 | 2015 | 60 | 0.120 |
Why?
| | Fatal Outcome | 2 | 2009 | 306 | 0.120 |
Why?
| | Antilymphocyte Serum | 3 | 2010 | 57 | 0.120 |
Why?
| | Antibodies, Neoplasm | 3 | 2010 | 34 | 0.120 |
Why?
| | Hyperglycemia | 2 | 2010 | 376 | 0.110 |
Why?
| | Multivariate Analysis | 3 | 2015 | 1544 | 0.110 |
Why?
| | Glycogen Storage Disease Type II | 1 | 2015 | 6 | 0.110 |
Why?
| | Survival Rate | 3 | 2016 | 2093 | 0.110 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2024 | 1417 | 0.110 |
Why?
| | Liver | 2 | 2022 | 1895 | 0.110 |
Why?
| | Immunosuppressive Agents | 6 | 2010 | 842 | 0.110 |
Why?
| | Aged, 80 and over | 7 | 2015 | 8326 | 0.110 |
Why?
| | Donor Selection | 1 | 2015 | 81 | 0.110 |
Why?
| | Kidney Function Tests | 1 | 2015 | 156 | 0.110 |
Why?
| | Family | 2 | 2017 | 687 | 0.100 |
Why?
| | United States | 5 | 2024 | 16115 | 0.100 |
Why?
| | Registries | 2 | 2021 | 2410 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2022 | 1244 | 0.100 |
Why?
| | California | 1 | 2015 | 483 | 0.100 |
Why?
| | Regression Analysis | 2 | 2014 | 1001 | 0.100 |
Why?
| | Electronic Health Records | 1 | 2022 | 1187 | 0.100 |
Why?
| | Insulin | 3 | 2010 | 2506 | 0.100 |
Why?
| | Child | 7 | 2020 | 22680 | 0.100 |
Why?
| | Geography | 1 | 2014 | 204 | 0.100 |
Why?
| | Pregnancy Trimester, Second | 1 | 2013 | 83 | 0.100 |
Why?
| | Global Health | 1 | 2016 | 404 | 0.100 |
Why?
| | Pancreatic Ducts | 2 | 2011 | 81 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1369 | 0.090 |
Why?
| | End Stage Liver Disease | 1 | 2014 | 95 | 0.090 |
Why?
| | Surgical Wound Infection | 4 | 2009 | 330 | 0.090 |
Why?
| | Young Adult | 7 | 2023 | 14192 | 0.090 |
Why?
| | Heart Transplantation | 1 | 2018 | 676 | 0.090 |
Why?
| | Hepatocytes | 2 | 2023 | 224 | 0.090 |
Why?
| | Contraindications | 1 | 2011 | 91 | 0.090 |
Why?
| | Aspartate Aminotransferases | 2 | 2012 | 85 | 0.090 |
Why?
| | Splenectomy | 1 | 2011 | 61 | 0.090 |
Why?
| | Bilirubin | 2 | 2012 | 99 | 0.080 |
Why?
| | Surgical Mesh | 2 | 2009 | 50 | 0.080 |
Why?
| | Hospital Mortality | 1 | 2015 | 1044 | 0.080 |
Why?
| | Cholestasis | 2 | 2012 | 213 | 0.080 |
Why?
| | Acetaminophen | 1 | 2013 | 266 | 0.080 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 252 | 0.080 |
Why?
| | Hypoglycemic Agents | 2 | 2010 | 1392 | 0.080 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4559 | 0.080 |
Why?
| | Sclerosis | 1 | 2009 | 11 | 0.070 |
Why?
| | Hemobilia | 1 | 2009 | 1 | 0.070 |
Why?
| | C-Peptide | 1 | 2010 | 190 | 0.070 |
Why?
| | Interferon-alpha | 1 | 2010 | 194 | 0.070 |
Why?
| | Atrophy | 1 | 2010 | 199 | 0.070 |
Why?
| | Paracentesis | 1 | 2009 | 16 | 0.070 |
Why?
| | HIV Infections | 1 | 2025 | 3189 | 0.070 |
Why?
| | Kidney Tubules | 1 | 2010 | 118 | 0.070 |
Why?
| | Physical Endurance | 1 | 2010 | 276 | 0.070 |
Why?
| | Plasmapheresis | 1 | 2009 | 24 | 0.070 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2012 | 235 | 0.070 |
Why?
| | Boronic Acids | 1 | 2009 | 36 | 0.070 |
Why?
| | Isoantibodies | 1 | 2009 | 57 | 0.070 |
Why?
| | Inpatients | 2 | 2010 | 550 | 0.070 |
Why?
| | Surgical Stapling | 1 | 2008 | 15 | 0.070 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 55 | 0.070 |
Why?
| | Hepatomegaly | 1 | 2008 | 4 | 0.070 |
Why?
| | Drug Overdose | 1 | 2013 | 374 | 0.070 |
Why?
| | Protease Inhibitors | 1 | 2009 | 101 | 0.070 |
Why?
| | Cadaver | 1 | 2009 | 309 | 0.070 |
Why?
| | Pyrazines | 1 | 2009 | 93 | 0.070 |
Why?
| | Liver Function Tests | 1 | 2008 | 105 | 0.070 |
Why?
| | Malnutrition | 1 | 2009 | 86 | 0.070 |
Why?
| | Pancreatitis | 1 | 2009 | 146 | 0.070 |
Why?
| | Abdominal Pain | 1 | 2009 | 149 | 0.070 |
Why?
| | Pancreatic Diseases | 1 | 2008 | 66 | 0.070 |
Why?
| | Adolescent | 5 | 2016 | 22485 | 0.060 |
Why?
| | HLA Antigens | 1 | 2009 | 238 | 0.060 |
Why?
| | Fibrosis | 1 | 2010 | 551 | 0.060 |
Why?
| | Liver Cirrhosis, Biliary | 1 | 2007 | 15 | 0.060 |
Why?
| | Incidental Findings | 1 | 2007 | 81 | 0.060 |
Why?
| | Decompression, Surgical | 1 | 2007 | 116 | 0.060 |
Why?
| | Societies, Medical | 2 | 2024 | 898 | 0.060 |
Why?
| | Diabetic Nephropathies | 1 | 2010 | 318 | 0.060 |
Why?
| | Prednisone | 1 | 2007 | 221 | 0.060 |
Why?
| | Tacrolimus | 1 | 2007 | 196 | 0.060 |
Why?
| | Lymph Node Excision | 1 | 2007 | 173 | 0.060 |
Why?
| | Iris Neoplasms | 1 | 2006 | 1 | 0.060 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2006 | 12 | 0.060 |
Why?
| | Aneurysm, False | 1 | 2006 | 46 | 0.060 |
Why?
| | Focal Nodular Hyperplasia | 1 | 2006 | 7 | 0.060 |
Why?
| | Treatment Failure | 1 | 2007 | 365 | 0.060 |
Why?
| | Anastomosis, Surgical | 1 | 2006 | 162 | 0.060 |
Why?
| | Sirolimus | 1 | 2007 | 280 | 0.060 |
Why?
| | Walking | 1 | 2010 | 542 | 0.060 |
Why?
| | Weight Gain | 1 | 2009 | 557 | 0.060 |
Why?
| | Lymphoproliferative Disorders | 1 | 2006 | 57 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2945 | 0.060 |
Why?
| | Alemtuzumab | 3 | 2010 | 15 | 0.060 |
Why?
| | Polyethylene Glycols | 1 | 2010 | 652 | 0.060 |
Why?
| | DNA Damage | 2 | 1999 | 434 | 0.060 |
Why?
| | Digestive System Surgical Procedures | 1 | 2006 | 112 | 0.050 |
Why?
| | Biopsy | 3 | 2016 | 1081 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3897 | 0.050 |
Why?
| | Adenoma | 1 | 2006 | 218 | 0.050 |
Why?
| | Mice | 2 | 2020 | 18338 | 0.050 |
Why?
| | HIV | 1 | 2025 | 252 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2010 | 2582 | 0.050 |
Why?
| | Neoplasm Staging | 1 | 2007 | 1468 | 0.050 |
Why?
| | Shock, Septic | 1 | 2005 | 226 | 0.050 |
Why?
| | Animals | 3 | 2024 | 38141 | 0.050 |
Why?
| | Informatics | 1 | 2022 | 7 | 0.050 |
Why?
| | Cell Separation | 1 | 2023 | 304 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2024 | 255 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2009 | 2146 | 0.040 |
Why?
| | Necrosis | 1 | 2022 | 244 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2024 | 551 | 0.040 |
Why?
| | Prospective Studies | 3 | 2022 | 8039 | 0.040 |
Why?
| | Mortality | 1 | 2022 | 379 | 0.040 |
Why?
| | Observer Variation | 1 | 2020 | 358 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2020 | 132 | 0.040 |
Why?
| | Quality of Life | 2 | 2010 | 3195 | 0.040 |
Why?
| | Cyclins | 1 | 1999 | 79 | 0.040 |
Why?
| | Plasmids | 2 | 1997 | 375 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2010 | 994 | 0.040 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 2 | 2009 | 97 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2023 | 580 | 0.030 |
Why?
| | Inflammation | 1 | 2010 | 2883 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2023 | 4127 | 0.030 |
Why?
| | Immunoglobulins, Intravenous | 2 | 2009 | 133 | 0.030 |
Why?
| | Renal Replacement Therapy | 1 | 2018 | 100 | 0.030 |
Why?
| | Rituximab | 2 | 2009 | 211 | 0.030 |
Why?
| | Allografts | 1 | 2018 | 153 | 0.030 |
Why?
| | Communication | 1 | 2024 | 975 | 0.030 |
Why?
| | Cholangiography | 1 | 2016 | 10 | 0.030 |
Why?
| | Flow Cytometry | 2 | 1999 | 1156 | 0.030 |
Why?
| | International Cooperation | 1 | 2017 | 197 | 0.030 |
Why?
| | Abdominal Neoplasms | 1 | 2016 | 47 | 0.030 |
Why?
| | DNA, Neoplasm | 1 | 1997 | 158 | 0.030 |
Why?
| | Drug Therapy, Combination | 2 | 2010 | 1046 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 2 | 2010 | 482 | 0.030 |
Why?
| | Ataxia Telangiectasia | 1 | 1996 | 18 | 0.030 |
Why?
| | Child, Preschool | 2 | 2013 | 11837 | 0.030 |
Why?
| | Cinnamates | 1 | 1996 | 12 | 0.030 |
Why?
| | Viral Load | 1 | 2018 | 528 | 0.030 |
Why?
| | Cell Cycle | 1 | 1999 | 595 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 1119 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 1999 | 620 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 37 | 0.030 |
Why?
| | alpha-Glucosidases | 1 | 2015 | 9 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 1997 | 883 | 0.030 |
Why?
| | Fibroblasts | 2 | 1999 | 1023 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1997 | 337 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 1068 | 0.030 |
Why?
| | Heart | 1 | 2018 | 626 | 0.030 |
Why?
| | Blotting, Western | 1 | 1997 | 1162 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 1999 | 743 | 0.030 |
Why?
| | DNA Repair | 1 | 1996 | 256 | 0.020 |
Why?
| | ROC Curve | 1 | 2015 | 619 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3917 | 0.020 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2013 | 41 | 0.020 |
Why?
| | Infant | 1 | 2007 | 10064 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1507 | 0.020 |
Why?
| | Hepatoblastoma | 1 | 2013 | 52 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 1997 | 2002 | 0.020 |
Why?
| | Alanine Transaminase | 1 | 2012 | 151 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 144 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 1999 | 1487 | 0.020 |
Why?
| | Recombinant Proteins | 2 | 2010 | 1367 | 0.020 |
Why?
| | Biomarkers | 2 | 2015 | 4283 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2013 | 505 | 0.020 |
Why?
| | Arizona | 1 | 2010 | 81 | 0.020 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2012 | 222 | 0.020 |
Why?
| | Ribavirin | 1 | 2010 | 81 | 0.020 |
Why?
| | Cohort Studies | 2 | 2011 | 5992 | 0.020 |
Why?
| | Medical History Taking | 1 | 2009 | 117 | 0.020 |
Why?
| | Blood Glucose | 2 | 2010 | 2330 | 0.020 |
Why?
| | DNA | 1 | 1996 | 1451 | 0.020 |
Why?
| | Ileus | 1 | 2009 | 13 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 529 | 0.020 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2009 | 24 | 0.020 |
Why?
| | Bortezomib | 1 | 2009 | 54 | 0.020 |
Why?
| | Bile Ducts | 1 | 2009 | 67 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3076 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 123 | 0.020 |
Why?
| | Hematologic Diseases | 1 | 2009 | 66 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 974 | 0.020 |
Why?
| | Diabetic Retinopathy | 1 | 2010 | 201 | 0.020 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 98 | 0.020 |
Why?
| | Poisoning | 1 | 2009 | 119 | 0.020 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 644 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 667 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2009 | 223 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1049 | 0.020 |
Why?
| | Acute Disease | 1 | 2010 | 1040 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 2009 | 176 | 0.020 |
Why?
| | Radiotherapy, Conformal | 1 | 2007 | 74 | 0.020 |
Why?
| | RNA, Viral | 1 | 2010 | 693 | 0.020 |
Why?
| | Hepatic Artery | 1 | 2006 | 53 | 0.010 |
Why?
| | Microsurgery | 1 | 2006 | 75 | 0.010 |
Why?
| | Angiography | 1 | 2006 | 211 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2129 | 0.010 |
Why?
| | Logistic Models | 1 | 2010 | 2130 | 0.010 |
Why?
| | Herpesvirus 4, Human | 1 | 2006 | 177 | 0.010 |
Why?
| | Colorectal Neoplasms | 1 | 2013 | 866 | 0.010 |
Why?
| | Genotype | 1 | 2009 | 1853 | 0.010 |
Why?
| | Safety | 1 | 2006 | 357 | 0.010 |
Why?
| | Cause of Death | 1 | 2006 | 469 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1896 | 0.010 |
Why?
| | Catheter Ablation | 1 | 2007 | 356 | 0.010 |
Why?
| | Age Factors | 1 | 2009 | 3340 | 0.010 |
Why?
| | Prevalence | 1 | 2009 | 2855 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2006 | 673 | 0.010 |
Why?
| | Neoplasms | 1 | 1997 | 2897 | 0.010 |
Why?
| | Body Mass Index | 1 | 2009 | 2425 | 0.010 |
Why?
| | Pregnancy | 1 | 2013 | 7197 | 0.010 |
Why?
| | DNA-Activated Protein Kinase | 1 | 1999 | 14 | 0.010 |
Why?
| | Infrared Rays | 1 | 1999 | 26 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2007 | 1585 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 1999 | 67 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1999 | 106 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 1999 | 234 | 0.010 |
Why?
| | Mice, SCID | 1 | 1999 | 369 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2185 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 1999 | 372 | 0.010 |
Why?
| | Hygromycin B | 1 | 1996 | 3 | 0.010 |
Why?
| | Simian virus 40 | 1 | 1996 | 24 | 0.010 |
Why?
| | Pentosyltransferases | 1 | 1996 | 6 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1996 | 81 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 1996 | 138 | 0.010 |
Why?
| | Cell Nucleus | 1 | 1999 | 593 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2007 | 2207 | 0.010 |
Why?
| | Sequence Deletion | 1 | 1996 | 191 | 0.010 |
Why?
| | Transfection | 1 | 1996 | 925 | 0.010 |
Why?
| | Cell Line | 1 | 1996 | 2823 | 0.000 |
Why?
|
|
Mekeel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|